Company Profile

Entvantage Dx (AKA: Entvantage Diagnostics Inc)
Profile last edited on: 2/9/2023      CAGE: 7KEK7      UEI: GYLLFDT5EXJ6

Business Identifier: Diagnostic tests accurately to distinguish bacterial from viral infections
Year Founded
2013
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4200 Marathon Boulevard Suite 200
Austin, TX 78756
   (512) 431-6071
   N/A
   www.entv-dx.com
Location: Single
Congr. District: 10
County: Travis

Public Profile

In a concerted effort to reduce the inappropriate prescribing of antibiotics for non-bacterial infections, Entvantage Dx is structured around development of in-office diagnostic test kit designed to determine the cause of ear, nose and throat illnesses. The firm's in-office diagnostic test kit provides primary care and ENT physicians with rapid diagnostic tests by which to determine the causes of ear, nose and throat illnesses. By qualitatively identifying the three major bacterial sinusitis pathogens and providing differentiation from viral sinusitis infections, physicians are enabled only to prescribe antibiotic treatment for patients who have bacterial sinusitis therefore reducing the unnecessary prescription of antibiotics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $2,488,837
Project Title: Sinu-Test, a Multiplexed Device for Rapid Diagnosis of Acute Bacterial Sinusitis

Key People / Management

  Joseph Skraba -- President & CEO

  Oriana E Hawkins

Company News

There are no news available.